Why is eczema herpeticum unexpectedly rare?

Antiviral Research

Volumn 98, Issue 2, 2013, Pages 153-157

  Leung, Donald Y M ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

Atopic dermatitis; Eczema herpeticum; Herpes simplex virus

Indexed keywords

ALLERGEN; FILAGGRIN; HOST FACTOR; IMMUNOGLOBULIN E; INTERFERON; ANTIVIRUS AGENT; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIVIRAL THERAPY; ATOPIC DERMATITIS; CLINICAL FEATURE; EOSINOPHIL COUNT; HERPES SIMPLEX VIRUS; IMMUNOGLOBULIN BLOOD LEVEL; KAPOSI VARICELLIFORM ERUPTION; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RARE DISEASE; TH2 CELL; HERPES SIMPLEX VIRUS 1; HUMAN; PROTEIN EXPRESSION; ARTICLE; FEMALE; IMMUNOLOGY; MALE;

BACTERIA (MICROORGANISMS); SIMPLEXVIRUS; STAPHYLOCOCCUS AUREUS;

DERMATITIS, ATOPIC; FEMALE; HUMANS; KAPOSI VARICELLIFORM ERUPTION; MALE; TH2 CELLS;

EID: 84875992865     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.02.010     Document Type: Note

References (31)

1. Ahmad-Nejad P., Mrabet-Dahbi S., Breuer K., Klotz M., Werfel T., Herz U., Heeg K., Neumaier M., Renz H. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J. Allergy Clin. Immunol. 2004, 113:565-567.
2. Barnes K.C. An update on the genetics of atopic dermatitis: Scratching the surface in 2009. J. Allergy Clin. Immunol. 2010, 125:16-29.
3. Beck L.A., Boguniewicz M., Hata T.R., Schneider L.C., Hanifin J.M., Gallo R.L., Paller A.S., Lieff S., Reese J., Zaccaro D., Milgrom H., Barnes K.C., Leung D.Y.M. Phenotype of atopic dermatitis: subjects with a history of eczema herpeticum. J. Allergy Clin. Immunol. 2009, 124:260-269.
4. Bin L., Brauweiler A., Goleva E., Streib J., Yinduo J., Schilevert P.M., Leung D.Y.M. Staphylococcus aureus α-toxin modulates skin host response to viral infection. J. Allergy Clin. Immunol. 2012, 130(683-691):e2.
5. Boguniewicz M., Leung D.Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol. Rev. 2011, 242:233-246.
6. Boguniewicz M., Leung D.Y. Recent insights into atopic dermatitis and implications for management of infectious complications. J. Allergy Clin. Immunol. 2010, 125:4-13.
7. Broccardo C.J., Mahaffey S., Schwarz J., Wruck L., David G., Schlievert P.M., Reisdorph N.A., Leung D.Y. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J. Allergy Clin. Immunol. 2011, 127:186-193. 93 e1-11.
8. De Benedetto A., Rafaels N.M., McGirt L.Y., Ivanov A.I., Georas S.N., Cheadle C., Berger A.E., Zhang K., Vidyasagar S., Yoshida T., Boguniewicz M., Hata T., Schneider L.C., Hanifin J.M., Gallo R.L., Novak N., Weidinger S., Beaty T.H., Leung D.Y., Barnes K.C., Beck L.A. Tight junction defects in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2011, 127:773-786.
9. De Benedetto A., Slifka M.K., Rafaels N.M., Kuo I.-H., Georas S.N., Boguniewicz M., Hata T.R., Schneider L.C., Hanifin J.M., Gallo R.L., Johnson D.C., Barnes K.C., Leung D.Y., Beck L.A. Reductions in Claudin-1 may enhance susceptibility to HSV-1 infections in atopic dermatitis. J. Allergy Clin. Immunol. 2011, 128:242-246.
10. Gao P.S., Rafaels N.M., Mu D., Hand T., Murray T., Boguniewicz M., Hata T., Schneider L., Hanifin J.M., Gallo R.L., Gao L., Beaty T.H., Beck L.A., Leung D.Y., Barnes K.C. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J. Allergy Clin. Immunol. 2010, 125:1403-1407.
11. Gao P.S., Rafaels N.M., Hand T., Murray T., Boguniewicz M., Hata T., Schneider L., Hanifin J.M., Gallo R.L., Gao L., Beaty T.H., Beck L.A., Barnes K.C., Leung D.Y. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J. Allergy Clin. Immunol. 2009, 124:507-513.
12. Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts. J. Allergy Clin. Immunol. 2011, 127:1110-1118.
13. Hata T.R., Kotol P., Boguniewicz M., Taylor P., Paik A., Jackson M., Nguyen M., Kabigting F., Miller J., Gerber M., Zaccaro D., Armstrong B., Dorschner R., Leung D.Y., Gallo R.L. History of eczema herpeticum is associated with the inability to induce human beta-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis. Br. J. Dermatol. 2010, 163:659-661.
14. Howell M.D., Gao P.S., Kim B.E., Lesley L.J., Streib J.E., Taylor P.A., Zaccaro D.J., Boguniewicz M., Beck L.A., Hanifin J.M., Schneider L.C., Hata T.R., Gallo R.L., Kaplan M.H., Barnes K.C., Leung D.Y.M. The signal transducer and activator of transcription 6 gene (STAT6) increases propensity of patient with atopic dermatitis patients toward disseminated viral skin infections. J. Allergy Clin. Immunol. 2011, 128:1006-1014.
15. Howell M.D., Kim B.E., Gao P., Grant A.V., Boguniewicz M., Debenedetto A., Schneider L., Beck L.A., Barnes K.C., Leung D.Y. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 2007, 120:150-155.
16. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., Leung D.Y. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006, 24:341-348.
17. Howell M.D., Wollenberg A., Gallo R.L., Flaig M., Streib J.E., Wong C., Pavicic T., Boguniewicz M., Leung D.Y.M. Cathelicidin deficiency predisposes to eczema herpeticum. J. Allergy Clin. Immunol. 2006, 117:836-841.
18. Irvine A.D., McLean W.H.I., Leung D.Y.M. Filaggrin mutations: associations with skin and allergic diseases. N. Engl. J. Med. 2011, 365:1315-1327.
19. Kempe C.H. Smallpox vaccination of eczema patients with attenuated live vaccinia virus. Yale J. Biol. Med. 1968, 41:1-12.
20. Koluman G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005, 202:637-650.
21. Laughter D., Istvan J.A., Tofte S.J., Hanifin J.M. The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol. 2000, 43:649-655.
22. Leung D.Y., Gao P.S., Grigoryev D.N., Rafaels N.M., Streib J.E., Howell M.D., Taylor P.A., Boguniewicz M., Canniff J., Armstrong B., Zaccaro D.J., Schneider L.C., Hata T.R., Hanifin J.M., Beck L.A., Weinberg A., Barnes K.C. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J. Allergy Clin. Immunol. 2011, 127(965-73):e1-e5.
23. Miajlovic H., Fallon Padraic G., Irvine A.D., McLean W.H.I., Foster T.J. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J. Allergy Clin. Immunol. 2010, 126:1184-1190.
24. Mikloska Z., Cunningham A.L. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 2001, 75:11821-11826.
25. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J Med. 2002, 347:1151-1160.
26. Oyoshi M.K., Murphy G.F., Geha R.S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J. Allergy Clin. Immunol. 2009, 124:485-493.
27. Reed J.L., Scott E.S., Bray M. Eczema Vaccinatum. Clin. Infect. Dis. 2012, 54:832-840.
28. Wollenberg A. Eczema herpeticum. Chem. Immunol. Allergy 2012, 96:89-95.
29. Wollenberg A., Zoch C., Wetzel S., Plewig G., Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J. Am. Acad. Dermatol. 2003, 49:198-205.
30. Wollenberg A., Wagner M., Gunther S., Towarowski A., Tuma E., Moderer M. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 2002, 119:1096-1102.
31. Xu F., Sternberg M.R., Kottiri B.J., McQuillan G.M., Lee F.K., Nahmias A.J., Berman S.M., Markowitz L.E. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006, 296:964-973.